Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (231-240 of 342) with videos related to

Pageof 35
Sort By:
BMC Neurology|October 24, 2012
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyMarta Giannini, Emilio Portaccio, Angelo Ghezzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2020
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS scoreAmy Kunchok, Jeannette Lechner-Scott, Franco Granella, et al.
BMC Neurology|January 2, 2013
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyLuisa Pastò, Emilio Portaccio, Angelo Ghezzi, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
BMC Neurology|September 11, 2014
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian populationBenedetta Goretti, Claudia Niccolai, Bahia Hakiki, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Pageof 35

Showing results (231-240 of 342) with videos related to

Sort By:
Pageof 35
BMC Neurology|October 24, 2012
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyMarta Giannini, Emilio Portaccio, Angelo Ghezzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2020
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS scoreAmy Kunchok, Jeannette Lechner-Scott, Franco Granella, et al.
BMC Neurology|January 2, 2013
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyLuisa Pastò, Emilio Portaccio, Angelo Ghezzi, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
BMC Neurology|September 11, 2014
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian populationBenedetta Goretti, Claudia Niccolai, Bahia Hakiki, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Pageof 35